MaineCare CMO on Planning for 1115 Medicaid Re-Entry Waiver
Courtney Pladsen, D.N.P, chief medical officer of MaineCare, said the state realized it needs to design sets of services tailored to each county individually
Courtney Pladsen, D.N.P, chief medical officer of MaineCare, said the state realized it needs to design sets of services tailored to each county individually
The defining capability of modern health plans is intelligent engagement with unified infrastructure. The post Smarter Engagement for Stronger Growth: How Payers Can Successfully Do More with Less appeared first on MedCity News.
AI genuinely could reduce barriers, by making health information more conversational, more personalized, and easier to act on. But that only happens if the people building these tools decide, from day one, that accessibility isn’t optional. The post AI Is Becoming the Front Door to Healthcare — But Millions of Patients Can’t Get Through It…
A newly diagnosed person experiences healthcare as a complicated maze of physicians, specialists, pharmacies, insurers, deductibles, formularies, prior authorizations, benefit explanations and coverage rules that rarely speak to one another and often contradict each other. Better AI can help. The post AI Made Healthcare Smarter – The Next Step is Making It Simpler appeared first…
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the diversion of a Detroit-bound plane to Canada over Ebola concerns on CBS News’ CBS Mornings on May 21. Gounder also discussed how the Democratic Republic of Congo’s Ebola outbreak has been declared a global health emergency on Fox’s LiveNOW on May 18. Click here…
Three health systems — Mount Sinai, Michigan Medicine and the University of Kansas Health System — are suing CVS Health, alleging its pharmacy benefit manager diverted roughly $250 million in savings from the 340B program through “spread pricing” between 2020 and 2025. The post Hospitals Take CVS to Court Over Alleged $250M 340B Scheme appeared…
Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.
During listening tour, stakeholders describe mixed experiences with selecting, implementing, and effectively exchanging data using a QHIO
President Donald Trump has long bantered about GLP-1s, the breakthrough medicines that have changed care for diabetes and obesity. Sometimes he calls them “the fat drug.” In an interview with the The New York Times in January, he mused that “I probably should” take them. A few days before the Times published that story, Trump…
Selective contracting, use of AI, networking volatility and interest in value-based care are some of the larger trends affecting the dental and vision benefits market. The post What Trends Are Shaping the Dental and Vision Benefits Market? appeared first on MedCity News.